Project Grant R01HL176713
- This federal Project Grant award for $696,470, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to investigate the relationship between prenatal maternal sleep and cardiovascular disease risk in offspring. The University of Denver is the primary awardee, and they have sub-awards with Northwestern University and the University of Colorado, Anschutz Medical Center. The key objectives are to: 1) examine how prenatal maternal sleep...
- This Project Grant award of $751,124 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Kaiser Foundation Hospitals supports research focused on the prevention of hypertensive disorders of pregnancy (HDP), which affect 10-15% of pregnancies and are risk factors for future cardiovascular disease in women. The key objectives are to explore the timing and intensity of physical activity, as well as the optimal 24-hour activity composition including...
- This federal Project Grant award of $727,080 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate the neurogenic mechanisms underlying psychosocial stress-induced cardiovascular disease and postpartum depression. The primary research objective is to delineate how stress-evoked mitochondrial dysfunction in the medial prefrontal cortex contributes to postpartum cardiovascular and behavioral changes. The 4-year project,...
- This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), will fund research to investigate place-based factors contributing to sleep health disparities in the United States. The $177,385 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, will: 1) Estimate sleep health measures and environmental circadian misalignment across different populations and geographies; 2) Examine...
- This Project Grant award of $790,584.00 from the National Heart, Lung, and Blood Institute (CFDA Program 93.837 - Cardiovascular Diseases Research) supports research to determine the optimal duration of overnight naps that restore normal blood pressure patterns and minimize performance impairment among night shift workers. The study, conducted by the University of Pittsburgh, aims to address the disproportionate cardiovascular disease risk faced by night shift workers in public safety and...
- The Maternal and Child Health Research Consortium was awarded a $560,061 Project Grant from the Health Resources and Services Administration (HRSA) under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110). The grant will fund a series of collaborative research studies, known as Project PITCH (Perinatal Incentivized Treatment and Care for Hypertension), to improve outcomes for women with hypertensive disorders of pregnancy (HDP). The key products and services to be...
- The National Heart, Lung, and Blood Institute awarded a $156,486 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Denver. The 5-year grant, running from July 2, 2025 to January 5, 2027, will support research examining the association between discrimination reported during pregnancy and cardiovascular disease risk in mothers 3-4 years postpartum. The study will use a prospective longitudinal design with a population of at least 200...
- This $275,196 federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research at the University of Chicago investigating the impact of adolescent reproductive health factors on the risk of cardiometabolic disease in young adult women. The project aims to analyze longitudinal data from the Pittsburgh Girls Study to examine associations between adolescent pubertal development, sexual health, and pregnancy history with...
- This $100,998 project grant awarded by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to The Regents of the University of California, San Francisco (UCSF) aims to evaluate the effects of universal pre-kindergarten (pre-K) access policies on the cardiovascular health of approximately 28 million parents of young children in the United States. The study will leverage the National Health Interview Survey to examine how parenthood, universal pre-K, and...
- This federal Project Grant award of $639,474, provided by the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), supports a study to investigate the impact of maternal mental health interventions on child respiratory health. The study aims to leverage an ongoing birth cohort in rural Pakistan to generate evidence on how childhood adversity, such as poverty and maternal depression, affects respiratory function and symptoms in early...
This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $616,864.00 to the University of Pittsburgh to conduct research on optimizing maternal health and reducing cardiovascular disease (CVD) risk factors during the perinatal period. The project, titled "Optimizing Maternal Health: Assessing Sleep-Based Strategy Enhancement of Diet, Physical Activity and Self-Regulation Interventions in Perinatal Health - CVD", aims to leverage data from the existing Health Behaviors in Transition (HABIT) study to estimate the effects of sleep-based strategies on improving perinatal weight management and overall health. The research team will utilize trial emulation techniques to analyze observational data and determine if maternal weight and health outcomes at one year postpartum can be enhanced through interventions that incorporate sleep health considerations, in addition to the standard diet and physical activity approaches. The award period runs from September 3, 2025 to June 30, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $616.9k | 9/3/25 |